Why is there a demand for artificial pancreas systems?

The increasing global prevalence of diabetes, encompassing both type 1 and type 2, is fueling demand for innovative solutions, making artificial pancreas systems a proactive approach to diabetes management.

How big is the Artificial Pancreas Device Systems Market?

The global Artificial Pancreas Device Systems Market size was estimated at USD 246.8 Million in 2023 and is expected to reach USD 1417.2 Million in 2033.

What is the Artificial Pancreas Device Systems Market growth?

The global Artificial Pancreas Device Systems Market is expected to grow at a compound annual growth rate of 19.1%. From 2024 To 2033

Who are the key companies/players in the Artificial Pancreas Device Systems Market?

Some of the key players in the Artificial Pancreas Device Systems Markets are Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson Services Inc., Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, Beta Bionics

What role does Continuous Glucose Monitoring (CGM) play in artificial pancreas devices?

Integration of CGM technology enhances the performance of artificial pancreas devices by providing accurate real-time data for insulin dose adjustments.

What is the current industry trend in artificial pancreas development?

The industry trend is shifting towards personalized and patient-centric solutions, emphasizing user experience, comfort, and customization to improve patient compliance.

What is a significant barrier to the widespread adoption of artificial pancreas systems?

The high costs associated with artificial pancreas systems act as a significant barrier to widespread adoption, necessitating a balance between innovation and cost-effectiveness.

Global Artificial Pancreas Device Systems Market By Device Type(Threshold Suspend Device Systems, Control-to-Range (CTR) Systems, Control-to-Target (CTT) Systems) By End-Use(Hospitals, Clinics, Other) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jun 2024
Report ID: 56270
Number of Pages: 385
Format:

- Medtronic Plc
- Bigfoot Biomedical
- Johnson & Johnson Services Inc.
- Tandem Diabetes Care, Inc.
- Pancreum, Inc.
- TypeZero Technologies, LLC
- Beta Bionics
Settings

Related Reports

Our Clients

Inquiry Before Buying

Artificial Pancreas Device Systems Market

Report ID 56270
Published Date Jun 2024
Rating
- ★★★★★
  
  ★★★★★
- (34)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)